oleanolic acid has been researched along with paclitaxel in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 5 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, M; Fu, L; Hasegawa, T; Hirose, K; Kataoka, T; Kiuchi, M; Li, N; Mitsui, T; Oka, S; Sakai, J; Wang, J; Zhang, S; Zhao, M | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Awale, S; Dang, PH; Duong, TTT; Nguyen, HX; Nguyen, MTT; Nguyen, NT; Nguyen, PT; Phan, NHT; Tran, TKT; Vu, TKT; Vuong, HC | 1 |
| Anaya-Eugenio, GD; Burdette, JE; Chai, HB; Czarnecki, AA; de Blanco, EJC; Kinghorn, AD; Ninh, TN; Ren, Y; Soejarto, DD; Yuan, C | 1 |
| Gao, X; Kang, H; Li, B; Liu, N; Liu, S; Liu, T; Liu, X; Long, X; Lu, C; Peng, J; Qi, M; Qin, S; Sun, T; Wei, M; Wei, Y; Xie, M; Xu, Z; Yang, C; Yang, G; Zhang, Z; Zhao, R; Zhou, H; Zhu, L | 1 |
| Chen, Z; Cheng, YY; Duan, HQ; Goto, M; Huang, KY; Lee, KH; Ling, Y; Liu, YL; Morris-Natschke, SL; Tong, XH; Yang, PC; Yang, SL | 1 |
| Arya, GC; Jaitak, V; Kaur, K | 1 |
| Ji, D; Kang, G; Wang, P; Xiang, F; Zhang, F | 1 |
| Chen, B; Du, B; Gong, Q; Ho, HI; Li, Q; Liu, X; Lu, Y; Tan, Y; Wang, K; Wu, W; Xiao, J; Yin, T; Zhan, Y; Zhang, F; Zhang, Y; Zou, Y | 1 |
| Bao, Y; Chen, AT; Chen, J; Chen, Z; Deng, G; Ma, J; Xu, W; Yao, G; Yu, ZQ; Zhang, S; Zhou, J | 1 |
| Chan, MT; Chen, B; Du, B; Gu, J; Ho, IH; Liu, Q; Liu, X; Tan, Y; Wang, K; Wei, X; Wu, WK; Xiao, J; Yin, T; Zhan, Y; Zhang, L; Zhang, W | 1 |
| Cheng, J; Han, Y; Qiao, W; Wang, J; Yang, X; Zhao, H | 1 |
| Qiao, W; Wang, J; Yang, X; Zhao, H | 1 |
1 review(s) available for oleanolic acid and paclitaxel
| Article | Year |
|---|---|
Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Isoxazoles | 2021 |
12 other study(ies) available for oleanolic acid and paclitaxel
| Article | Year |
|---|---|
Three new triterpenes from Nerium oleander and biological activity of the isolated compounds.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Drug Screening Assays, Antitumor; Humans; Intercellular Adhesion Molecule-1; Japan; Models, Biological; Molecular Structure; Nerium; Oleanolic Acid; Plant Leaves; Plants, Medicinal; Triterpenes; Tumor Cells, Cultured | 2005 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
α-Glucosidase Inhibitory and Cytotoxic Taxane Diterpenoids from the Stem Bark of Taxus wallichiana.
Topics: alpha-Glucosidases; Antineoplastic Agents, Phytogenic; Bridged-Ring Compounds; Diterpenes; Glycoside Hydrolase Inhibitors; Humans; Molecular Structure; Paclitaxel; Plant Bark; Taxoids; Taxus | 2017 |
Cytotoxic and NF-κB and mitochondrial transmembrane potential inhibitory pentacyclic triterpenoids from Syzygium corticosum and their semi-synthetic derivatives.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; HT29 Cells; Humans; Membrane Potential, Mitochondrial; Molecular Conformation; NF-kappa B; Plant Extracts; Plant Leaves; Structure-Activity Relationship; Syzygium; Triterpenes; Ursolic Acid | 2018 |
Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids.
Topics: Antineoplastic Agents; Apoptosis; Biological Products; Caspases; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Chemistry Techniques, Synthetic; Drug Design; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Humans; Neoplastic Stem Cells; Reactive Oxygen Species; Triterpenes | 2018 |
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
Topics: A549 Cells; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Design; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Mutation; Nitric Oxide; Nitric Oxide Donors; Oleanolic Acid; Protein Kinase Inhibitors | 2019 |
Asymmetric somatic hybridization between Bupleurum scorzonerifolium Willd. and Taxus chinensis var. mairei.
Topics: Bupleurum; Gene Expression Regulation, Plant; Genome, Plant; Hybridization, Genetic; Oleanolic Acid; Paclitaxel; Protoplasts; Random Amplified Polymorphic DNA Technique; Taxus; Tissue Culture Techniques | 2011 |
The Novel Autophagy Inhibitor Alpha-Hederin Promoted Paclitaxel Cytotoxicity by Increasing Reactive Oxygen Species Accumulation in Non-Small Cell Lung Cancer Cells.
Topics: Apoptosis; Autophagosomes; Autophagy; Carcinoma, Non-Small-Cell Lung; Cathepsins; Cell Line, Tumor; Cell Proliferation; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Lysosomes; Oleanolic Acid; Paclitaxel; Reactive Oxygen Species; Saponins; Tubulin Modulators | 2018 |
Synergistic Chemotherapy for Breast Cancer and Breast Cancer Brain Metastases via Paclitaxel-Loaded Oleanolic Acid Nanoparticles.
Topics: Animals; Antineoplastic Agents; Brain; Brain Neoplasms; Breast Neoplasms; Cell Line, Tumor; Drug Synergism; Female; Humans; Mice; Mice, Nude; Nanoparticles; Oleanolic Acid; Paclitaxel | 2020 |
Hederagenin potentiated cisplatin- and paclitaxel-mediated cytotoxicity by impairing autophagy in lung cancer cells.
Topics: Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Cell Proliferation; Cisplatin; Humans; Lung Neoplasms; Lysosomes; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Oleanolic Acid; Paclitaxel; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2020 |
Nanomedicine-Cum-Carrier by Co-Assembly of Natural Small Products for Synergistic Enhanced Antitumor with Tissues Protective Actions.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biological Products; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Glycyrrhetinic Acid; Humans; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Molecular Conformation; Nanomedicine; Nanoparticles; Oleanolic Acid; Paclitaxel; Particle Size; Stereoisomerism; Surface Properties | 2020 |
Paclitaxel and betulonic acid synergistically enhance antitumor efficacy by forming co-assembled nanoparticles.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanoparticles; Oleanolic Acid; Paclitaxel; Treatment Outcome; Xenograft Model Antitumor Assays | 2020 |